Clinical features and management outcomes of severe hand, foot and mouth disease

Medical Principles and Practice

Volumn 21, Issue 4, 2012, Pages 355-359

  Tian, Hui ^a   Yang, Qiao Zhi ^a   Liang, Jun ^a   Dong, Sheng Ying ^a   Liu, Zhi Jun ^a   Wang, Le Xin ^b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Enterovirus 71; Hand, foot and mouth disease; Mechanical ventilation; Mortality

Indexed keywords

AMRINONE; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; IMMUNOGLOBULIN; MANNITOL; MIDAZOLAM; RIBAVIRIN;

ARTICLE; ARTIFICIAL VENTILATION; BRADYPNEA; CHILD; CLINICAL FEATURE; DROWSINESS; ENTEROVIRUS 71; FEMALE; FEVER; HAND FOOT AND MOUTH DISEASE; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFANT; LACTATE BLOOD LEVEL; LETHARGY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RASH; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CHILD, PRESCHOOL; CHINA; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; MALE; RESPIRATION DISORDERS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 84862164501     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000334619     Document Type: Article

References (18)

1. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T: Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010;9:1097-1105.
2. Chan L, Parashar U, Lye M, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, Jegathesan M, Anderson LJ: Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis 2000;31:678-683. (Pubitemid 32295486)
3. Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, Chang HJ, Lin TY: Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 2002;109:e88.
4. Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT: An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 2007;77:188-191.
5. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, Zhang Y, Yan D, Li Q, Dong X, Zhang J, Zhao Y, Wan J, Feng Z, Sun J, Wang S, Li D, Xu W: An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2010;7:94.
6. Mirand A, Schuffenecker I, Henquell C, Billaud G, Jugie G, Falcon D, Mahul A, Archimbaud C, Terletskaia-Ladwig E, Diedrich S, Huemer HP, Enders M, Lina B, Peigue-Lafeuille H, Bailly JL: Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries. J General Virol 2010;91:2263-2277.
7. Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen ML, Vuorinen T, Roivainen M: Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol 2010;48:49-54.
8. Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng CH, Tio PH, Cardosa MJ, Solomon T: Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis 2009;9:3.
9. Chinese Ministry of Health: Prevention and control guidelines for hand, foot and mouth disease. http://www.gov.cn/gzdt/2008-05/03/content-960347.htm (accessed on 6 January 2011).
10. Chinese Ministry of Health: Diagnosis and treatment guidelines for human enterovirus EV71. http://disease.39.net/ek/crxjb/085/8/409737.html (accessed on 6 January 2011).
11. http://www.emedicinehealth.com/pediatric-vital-signs/article-em.htm (accessed on 2 June 2011).
12. Ooi MH, Wong SC, Podin Y, Akin W, del Sel S, Mohan A, Chieng CH, Perera D, Clear D, Wong D, Blake E, Cardosa J, Solomon T: Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis 2007;44:646-656.
13. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF: Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999;341:936-942.
14. Lu HK, Lin TY, Hsia SH, Chiu CH, Huang YC, Tsao KC, Chang LY: Prognostic implications of myoclonic jerk in children with enterovirus infection. J Microbiol Immunol Infect 2004;37:82-87. (Pubitemid 38828590)
15. Chang LY, Hsia SH, Wu CT, Huang YC, Lin KL, Fang TY, Lin TY: Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J 2004;23:327-331.
16. Prager P, Nolan M, Andrews IP, Williams GD: Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors. Pediatr Crit Care Med 2003;4:377-381.
17. Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK, Chen SH: Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 2008;197:854-857. (Pubitemid 351417008)
18. Wang SM, Lei HY, Huang MC, Wu JM, Chen CT, Wang JN, Wang JR, Liu CC: Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol 2005;39:219-223.